Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
10/2007
10/31/2007EP1246795B1 Antibacterial agents
10/31/2007CN101065377A Imidazo[1,2-a]pyridine compounds, compositions, uses and methods related thereto
10/31/2007CN101065363A Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
10/31/2007CN101065359A Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery
10/31/2007CN100345849C Enantiomer (-) of tenatoprazole and the therapeutic use thereof
10/31/2007CN100345844C Quinazoline derivatives for the treatment of tumours
10/30/2007US7288559 Carboxamide spirohydantoin CGRP receptor antagonists
10/25/2007WO2007120101A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
10/25/2007US20070249840 Process for the preparation of bis-benzazolyl compounds
10/25/2007US20070249661 Compounds for inflammation and immune-related uses
10/25/2007US20070249630 Phenethanolamine derivatives for treatment of respiratory diseases
10/25/2007US20070249604 3-Monosubstituted tropane derivatives as nociceptin receptor ligands
10/25/2007US20070249600 Chemical compounds
10/25/2007US20070246134 Phenylnaphthylimidazole Compound and Usage of the Same
10/25/2007CA2649287A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
10/24/2007CN101058561A Diphenylurea derivative for inhibiting protein kinase, and composition and use thereof
10/24/2007CN100344614C Difluoro methyl amido benzimadazoles, and preparation method
10/23/2007US7285568 Substituted p-(2-alkoxy-2-acylethyl)biphenyl compounds, e.g., 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; useful in human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases, and diseases associated with lipid metabolism
10/23/2007US7285551 For use as therapeutic agent and prophylactic agent for hepatitis C
10/23/2007US7285518 Dibenzo[b]perhydroheterocyclic amines and lubricating oil compositions
10/18/2007WO2007116314A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
10/18/2007WO2007116061A1 1-(2-aryl-2-oxoethyl)-3-phenyl-1, 4-diazaspiro [4.5]dec-3-en-2-one derivatives and their use as glycine transporter inhibitors
10/18/2007US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders
10/18/2007CA2648978A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
10/17/2007EP1845096A1 12-Aza-epothilones, process for their preparation and their use as antiproliferative agents
10/17/2007EP1592669B1 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
10/17/2007EP1341769B1 Bacterial gyrase inhibitors and uses thereof
10/17/2007CN101056881A Metal complex compound and organic electroluminescent device using same
10/17/2007CN100343285C Heterocyclic alkoxyl amine as regulator in controlled free radical polymerization method
10/17/2007CN100343251C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/16/2007US7282518 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
10/16/2007US7282515 Using 1,3-diazaspiro( 4.5)decane-2,4-(dione or dithione)
10/11/2007CA2646755A1 Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor potentiators
10/10/2007EP1490058B1 Peroxisome proliferator activated receptor modulators
10/10/2007CN101052639A Benzimidazole derivatives, composition containing thereof, its preparation method and application
10/09/2007US7279502 Such as prostate cancer, prostatitis and benign prostatic hyperplasia; ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane
10/09/2007US7279496 suitable for the prophylaxis or treatment of psychoses, schizophrenia, depression, anxiety states, dementia, in particular Alzheimer's disease and Lewy bodies dementia, neurodegenerative disorders, etc.
10/09/2007US7279495 Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control
10/09/2007US7279490 Ophthalmic compositions for treating ocular hypertension
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/04/2007WO2007111262A1 Nitrogen-containing heterocyclic derivative and organic electroluminescent device using same
10/04/2007WO2007111179A1 Diagnostic imaging agent for incurable neuron disease
10/04/2007WO2007111136A1 Curable epoxy resin composition
10/04/2007WO2007110374A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/04/2007WO2007110363A1 Novel guanidine derivatives and their medical use
10/04/2007WO2007110214A1 12-aza-ep0thil0nes, process for their preparation and their use as antiproliferative agents
10/04/2007US20070232673 2-Imino-benzimidazoles
10/04/2007CA2647252A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/03/2007EP1838306A1 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
10/03/2007EP1599167B1 Benzimidazole and imidazopyridine derivatives having affinity for the melanocortin receptors and use thereof as a medicament
10/03/2007EP1519932B1 Bisarylsulfonamide compounds and their use in cancer therapy
10/03/2007CN101048383A 促性腺激素释放激素受体拮抗剂 Gonadotropin-releasing hormone receptor antagonist
10/03/2007CN101048382A New indole or benzimidazole derivatives
10/02/2007US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides
10/02/2007CA2096407C Retroviral protease inhibitors
09/2007
09/30/2007CA2541444A1 Process for preparing n,n'-carbonyldiazoles
09/27/2007WO2007108754A1 Crystalline forms of n- {2-tert -butyl -1- [ (4,4- dif luorocyclohexyl) methyl] -lh-benzimidazol-5- yl}ethanesulfonamide salts
09/27/2007WO2007107567A1 Benzimidazoles which have activity at m1 receptor and their uses in medicine
09/27/2007WO2007107566A1 Benzimidazoles which have activity at m1 receptor and their uses in medicine
09/27/2007WO2007107356A1 Method for preparing doped organic semiconductor materials and formulation utilized therein
09/27/2007WO2007107311A2 Organic sulphinic acid derivatives
09/27/2007US20070225346 Crystalline Forms
09/27/2007US20070225327 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
09/27/2007US20070225266 Spiropiperidylrifamycins for the Treatment of Mycobacterial Infections
09/27/2007CA2648829A1 Crystalline forms of n-{2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1h-benzimidazol-5-yl}ethanesulfonamide salts
09/26/2007EP1837926A1 Heterocyclic radicals or diradicals and their dimers, oligomers, polymers, di-spiro and polycyclic derivatives as well as their use in organic semiconductor materials and electronic devices.
09/26/2007EP1837329A1 Novel heteroaryl derivative
09/26/2007EP1836166A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/26/2007EP1836161A2 Methods and compositions for treating amyloid-related diseases
09/26/2007CN100339079C Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them
09/25/2007US7273878 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
09/25/2007US7273863 Benzophenones as inhibitors of reverse transcriptase
09/25/2007US7273857 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes
09/25/2007CA2547947C Azole derivatives as active superoxide radical inhibitors
09/20/2007WO2007105023A1 Modulation of phosphoryl transferase activity of glutamine synthetase
09/20/2007WO2007104776A1 N-phenyl-2-0x0-1,4-diazaspir0 [4.5] dec-3-en-1-yl acetamide derivatives and their use as glycine transporter inhibitors
09/20/2007WO2007104775A1 Compounds which inhibit the glycine transporter and uses thereof
09/20/2007WO2007104696A1 Antimalarial agents having polyaromatic structure
09/20/2007WO2007087518A3 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
09/20/2007WO2007084390A3 Histone deacetylase inhibitors
09/20/2007US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both
09/19/2007EP1198456B1 Potassium channel openers
09/19/2007CN101039917A Process for preparing telmisartan
09/19/2007CN101037414A [(2-n-propyl-4-methyl-1H-Benzimidazole)6-radical] carboxamide-1-radical] methylbiphenyl compound, synthesizing method and usage
09/19/2007CN100338073C Substituted phenylacetic acids
09/19/2007CN100338050C Amine acid salt compounds and process for the production thereof
09/19/2007CN100338040C Xanthine oxidase inhibitors
09/18/2007US7271271 Imidazolo-related compounds, compositions and methods for their use
09/18/2007US7271270 High affinity small molecule C5a receptor modulators
09/18/2007US7271261 Useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2)
09/13/2007WO2007103111A2 Antiviral drugs for treatment of arenavirus infection
09/13/2007WO2007102059A1 Sulfonyl benzimidazole derivatives
09/13/2007WO2007011445A3 Synergistic composition and method for inhibiting growth of microorganisms
09/13/2007WO2006121528A3 Ring closing and related methods and intermediates
09/13/2007WO2006099567A3 Biocidal n-halamine epoxides
09/13/2007US20070213539 Novel synthesis of irbesartan
09/13/2007US20070213385 New derivatives of 4,5,6,7-tetrabromobenzimidazole and method of their preparation
09/13/2007US20070213379 Malonamides and malonamide derivatives as modulators of chemokine receptor activity
09/13/2007US20070213364 Alkoxyphenylpropanoic Acid Derivatives
09/13/2007US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 154